1H-4(5)-substituted imidazole derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514396, 5483351, 5483355, 5483411, 5483461, A61K 31417, A61K 314174, C07D23364

Patent

active

061660604

ABSTRACT:
The present invention provides, in its principal aspect, compounds of the general formula: ##STR1## when A is --NHCO--, --N(CH.sub.3)--CO--, --NHCH.sub.2 --, --N(CH.sub.3)--CH.sub.2 --, --CH.dbd.CH--, --COCH.sub.2 --, CH.sub.2 CH.sub.2 --, --CH(OH)CH.sub.2 -- or --C.tbd.C--;

REFERENCES:
patent: 4517198 (1985-05-01), Kurkela et al.
patent: 4568686 (1986-02-01), Karjalainen et al.
patent: 4707487 (1987-11-01), Arrang et al.
patent: 5010095 (1991-04-01), Sterk et al.
patent: 5173502 (1992-12-01), Malen et al.
patent: 5217986 (1993-06-01), Pomponi et al.
patent: 5248689 (1993-09-01), Girard et al.
patent: 5290790 (1994-03-01), Arrang et al.
patent: 5559113 (1996-09-01), Schwartz et al.
(Schwartz, 1975) Life Sci. 1.7: 503-518.
(Inagaki et al., 1988) J. Comp. Neurol. 273: 283-300.
(Schwartz et al., 1986) TIPS 8: 24-28.
Babizhayel et al., "Pseudodipeptide product, etc.", CA 123:286746 (1995).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

1H-4(5)-substituted imidazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1H-4(5)-substituted imidazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1H-4(5)-substituted imidazole derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-995381

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.